Tranexamic Acid in the Management of Non-variceal Upper Gastrointestinal Bleeding

Authors

  • Muhammad Reza Faculty of Medicine, Universitas Indonesia
  • Saskia Aziza Nursyirwan Internal Medicine Department, Cipto Mangunkusumo National General Hospital, Faculty of Medicine, Universitas Indonesia

DOI:

https://doi.org/10.24871/251202483-93

Keywords:

Non-variceal gastrointestinal bleeding, UGIB, tranexamic acid, placebo

Abstract

Background: Non-variceal upper gastrointestinal bleeding (UGIB) is a common case of emergency in daily clinical practice with a fairly high mortality rate. The use of tranexamic acid, which has been recommended in managing trauma bleeding, may serve as an alternative pharmacological therapy to manage bleeding in non-variceal UGIB. This evidence-based case report aims to evaluate the impact of tranexamic acid on managing bleeding, risk of mortality, and thromboembolic event in non-variceal UGIB patients.

Methods: A systematic literature search was conducted on 4 databases: CDSR, EMBASE, PubMed, and Scopus for meta-analyses. Studies were selected based on inclusion and exclusion criteria formulated a-priori with subsequent critical appraisal according to the OCEBM critical appraisal tools.

Result: Meta analyses by Kamal, et al (2020) and Twum-Barimah, et al (2020) were included in our report. Kamal, et al shows no significant difference in mortality in tranexamic acid use compared to placebo (RR 0.84; 95%CI 0.63–1.11; I2=2%). Similarly, although Twum-Barimah reported tranexamic acid reduced risk of mortality compared to placebo (RR 0.45; 95%CI 0.23–0.88; p=0.02; I2 = 0%), none of the RCTs included shows significant result when observed individually. In addition, Kamal, et al also reported increased risk of vein thromboembolic events in high-dose tranexamic acid administration (RR 2.21; 95%CI 1.32–3.69; I2=0%) compared to low-dose administration, in UGIB patients.

Conclusion: Tranexamic acid is not recommended to be used in managing bleeding in patients non-variceal UGIB patients and may increase the risk of thromboembolic event.

References

Indonesian Society of Gastroenterology. National consensus on management of non-variceal upper gastrointestinal tract bleeding in Indonesia. Acta Med Indones. 2014 Apr;46(2):163–71.

Antunes C, Copelin II EL. Upper gastrointestinal bleeding. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 [cited 2023 Jul 2]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK470300/

Malik TF, Gnanapandithan K, Singh K. Peptic ulcer disease. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 [cited 2023 Jul 2]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK534792/

Sharma A, Nagalli S. Chronic liver disease. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 [cited 2023 Jul 2]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK554597/

Khan MA, Howden CW. The role of proton pump inhibitors in the management of upper gastrointestinal disorders. Gastroenterol Hepatol (N Y). 2018 Mar;14(3):169–75.

Cai J, Ribkoff J, Olson S, Raghunathan V, Al-Samkari H, DeLoughery TG, et al. The many roles of tranexamic acid: An overview of the clinical indications for TXA in medical and surgical patients. Eur J Haematol. 2020 Feb;104(2):79–87.

Oxford University Centre for Evidence-Based Medicine. Critical appraisal tools [Internet]. Centre for Evidence-Based Medicine; 2022. Available from: https://www.cebm.ox.ac.uk/files/ebm-tools/systematic-review.pdf

Oxford University Centre for Evidence-Based Medicine. Oxford centre for evidence-based medicine 2011 levels of evidence [Internet]. Centre for Evidence-Based Medicine; 2022. Available from: https://www.cebm.ox.ac.uk/files/levels-of-evidence/cebm-levels-of-evidence-2-1.pdf

Kamal F, Khan MA, Lee-Smith W, Sharma S, Imam Z, Jowhar D, et al. Efficacy and safety of tranexamic acid in acute upper gastrointestinal bleeding: meta-analysis of randomised controlled trials. Scandinavian Journal of Gastroenterology. 2020 Dec 1;55(12):1390–7.

Twum-Barimah E, Abdelgadir I, Gordon M, Akobeng AK. Systematic review with meta-analysis: the efficacy of tranexamic acid in upper gastrointestinal bleeding. Alimentary Pharmacology & Therapeutics. 2020;51(11):1004–13.

Laine L. Gastrointestinal bleeding. In: Harrison’s principles of internal medicine. 19th ed. New York: McGraw-Hill; 2015. p. 276–9.

Laine L, Jensen DM. Management of patients with ulcer bleeding. Am J Gastroenterol. 2012 Mar;107(3):345–60; quiz 361.

Acute upper gastrointestinal bleeding in over 16s: management [Internet]. London: National Institute for Health and Care Excellence (NICE); 2016 [cited 2023 Jul 15]. (National Institute for Health and Care Excellence: Guidelines). Available from: http://www.ncbi.nlm.nih.gov/books/NBK554919/

Green FW, Kaplan MM, Curtis LE, Levine PH. Effect of acid and pepsin on blood coagulation and platelet aggregation. A possible contributor prolonged gastroduodenal mucosal hemorrhage. Gastroenterology. 1978 Jan;74(1):38–43.

Ghassemi KA, Kovacs TOG, Jensen DM. Gastric acid inhibition in the treatment of peptic ulcer hemorrhage. Curr Gastroenterol Rep. 2009 Dec;11(6):462–9.

Downloads

Published

2024-05-27

How to Cite

Reza, M., & Nursyirwan, S. A. (2024). Tranexamic Acid in the Management of Non-variceal Upper Gastrointestinal Bleeding. The Indonesian Journal of Gastroenterology, Hepatology, and Digestive Endoscopy, 25(1), 83–93. https://doi.org/10.24871/251202483-93